Log in
Enquire now
‌

US Patent 11891434 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Date Filed
May 24, 2018
0
Date of Patent
February 6, 2024
0
Patent Application Number
15988348
0
Patent Citations
‌
US Patent 7662925 Optimized Fc variants and methods for their generation
0
‌
US Patent 10385122 Nucleic acids encoding anti-C5 antibodies
0
‌
US Patent 10472623 Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
0
‌
US Patent 10519229 Nucleic acids encoding IL-8 antibodies
0
‌
US Patent 10618965 Method for altering plasma retention and immunogenicity of antigen-binding molecule
0
‌
US Patent 10662245 Methods of reducing IL-6 activity for disease treatment
0
‌
US Patent 10738111 Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
0
‌
US Patent 10774148 Composition for treating IL-6-related diseases
0
‌
US Patent 11053308 Method for treating IL-8-related diseases
0
‌
US Patent 11180548 Methods of neutralizing IL-8 biological activity
0
•••
Patent Inventor Names
Shun Shimizu
0
Shinya Ishii
0
Miho Funaki
0
Junichi Nezu
0
Yoshinao Ruike
0
Naoka Hironiwa
0
Tomoyuki Igawa
0
Atsuhiko Maeda
0
Takeshi Baba
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11891434
0
Patent Primary Examiner
‌
Phuong Huynh
0

Find more entities like US Patent 11891434 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.